Tuesday, October 23, 2018
- 9:00AM-11:00AM
-
Abstract Number: 2464
Clinimetric and Drug Use Differences in Colombian Patients with Early and Established Rheumatoid Arthritis
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III: Complications of Therapy, Outcomes, and Measures- 9:00AM-11:00AM
-
Abstract Number: 2277
Colchicine: An Effective Treatment Option for Unclassified Autoinflammatory Diseases in Children
Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease- 9:00AM-11:00AM
-
Abstract Number: 2635
Combined Panel of Nine Tests Has the Greatest Sensitivity but the Lowest Specificity to Detect Antiphospholipid Antibody Syndrome in Patients with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2768
Comorbidity Accrual and Mortality in an Inception Cohort of Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Single-Center, Observational Long-Term Study
Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 2133
Comparative Disease Burden of Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Data from the Corrona Rheumatoid Arthritis and Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registries
Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases- 9:00AM-11:00AM
-
Abstract Number: 2060
Comparative Histologic and Molecular Analysis of Synovial Tissue in Early Treatment-Naïve Psoriatic and Rheumatoid Arthritis
Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: L09
Comparative Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors: A Cohort Study of Rheumatoid Arthritis Patients
Late-Breaking Abstract Poster Session- 9:00AM-11:00AM
-
Abstract Number: 2581
Comparing Treatment Patterns of Non-Radiographic Axial Spondyloarthritis Patients in the United States and Europe
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2754
Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients
Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 2244
Comparison of an Interactive Voice Response (IVR) to Smart Phone App to Determine Patient Preference for Reporting Gout Flares
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 2024
Comparison of B and T Cell Subsets, Cytokine Expression and Synovial Pathology in Down’s Arthritis (DA) and Juvenile Idiopathic Arthritis (JIA)
Pediatric Rheumatology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 2663
Comparison of Clinical and Laboratory Profiles in 3575 Systemic Lupus Erythematosus Patients with and without Sjögren’s Syndrome: Data from the Spanish Society for Rheumatology Lupus Registry
Systemic Lupus Erythematosus – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2711
Comparison of Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis with That Associated with Other Diseases: Are There Differences?
Systemic Sclerosis and Related Disorders – Clinical Poster III- 9:00AM-11:00AM
-
Abstract Number: 2647
Comparison of Low-Dose Intravenous Cyclophosphamide with Oral Mycophenolate Mofetil in the Treatment of Lupus Nephritis: Long Term Follow-up Data